Compounds > 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin
Page last updated: 2024-09-05

3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and buthionine sulfoximine

3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin has been researched along with buthionine sulfoximine in 1 studies

Compound Research Comparison

Studies
(3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin)		Trials
(3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin)		Recent Studies (post-2010)
(3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin)		Studies
(buthionine sulfoximine)		Trials
(buthionine sulfoximine)		Recent Studies (post-2010) (buthionine sulfoximine)
38002,4608408

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Durán, GE; Lau, DH; Lewis, AD; Sikic, BI1

Other Studies

1 other study(ies) available for 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and buthionine sulfoximine

ArticleYear
Sensitization of drug resistant human ovarian cancer cells to cyanomorpholino doxorubicin (MRA-CN) by modulation of glutathione metabolism.
    International journal of radiation oncology, biology, physics, 1992, Volume: 22, Issue:4

    Topics: Antibiotics, Antineoplastic; Buthionine Sulfoximine; Cell Survival; Doxorubicin; Drug Resistance; Ethacrynic Acid; Female; Glutathione; Humans; In Vitro Techniques; Methionine Sulfoximine; Ovarian Neoplasms; Tumor Cells, Cultured

1992